News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,057 Results
Type
Article (13822)
Company Profile (102)
Press Release (253133)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88211)
Career Advice (465)
Deals (15375)
Drug Delivery (67)
Drug Development (36634)
Employer Resources (49)
FDA (6313)
Job Trends (6209)
News (150482)
Policy (14063)
Tag
Academia (442)
Accelerated approval (2)
Adcomms (6)
Allergies (36)
Alliances (23266)
ALS (37)
Alzheimer's disease (394)
Antibody-drug conjugate (ADC) (42)
Approvals (6353)
Artificial intelligence (112)
Autoimmune disease (9)
Automation (4)
Bankruptcy (150)
Best Places to Work (4376)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (84)
Cancer (646)
Cardiovascular disease (72)
Career advice (409)
Career pathing (12)
CAR-T (23)
Cell therapy (90)
Cervical cancer (4)
Clinical research (30965)
Collaboration (353)
Compensation (159)
Complete response letters (17)
COVID-19 (759)
CRISPR (22)
C-suite (128)
Cystic fibrosis (37)
Data (667)
Denatured (15)
Depression (10)
Diabetes (83)
Diagnostics (1345)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (66)
Drug shortages (12)
Duchenne muscular dystrophy (37)
Earnings (32275)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (38123)
Executive appointments (400)
FDA (6757)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (216)
Gene editing (40)
Generative AI (9)
Gene therapy (101)
GLP-1 (350)
Government (1302)
Grass and pollen (3)
Guidances (23)
Healthcare (3587)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (35)
Indications (14)
Infectious disease (794)
Inflammatory bowel disease (56)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (59)
IPO (5902)
IRA (29)
Job creations (2052)
Job search strategy (373)
Kidney cancer (6)
Labor market (12)
Layoffs (181)
Leadership (4)
Legal (3437)
Liver cancer (19)
Lung cancer (87)
Lymphoma (57)
Machine learning (2)
Management (16)
Manufacturing (163)
MASH (34)
Medical device (1303)
Medtech (1305)
Mergers & acquisitions (9682)
Metabolic disorders (267)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (584)
NextGen: Class of 2025 (1592)
Non-profit (602)
Now hiring (8)
Obesity (152)
Opinion (119)
Ovarian cancer (22)
Pain (54)
Pancreatic cancer (15)
Parkinson's disease (47)
Partnered (7)
Patents (121)
Patient recruitment (30)
Peanut (10)
People (29047)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8060)
Phase II (13106)
Phase III (11751)
Pipeline (472)
Policy (72)
Postmarket research (1402)
Preclinical (3236)
Press Release (25)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (170)
Real estate (2639)
Recruiting (17)
Regulatory (10155)
Reports (14)
Research institute (569)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (38)
Series B (13)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1636)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (32)
The Weekly (30)
Vaccines (156)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (4)
Date
Today (65)
Last 7 days (279)
Last 30 days (899)
Last 365 days (11750)
2025 (3931)
2024 (12537)
2023 (14307)
2022 (19622)
2021 (20132)
2020 (19090)
2019 (14982)
2018 (11790)
2017 (13921)
2016 (13177)
2015 (15538)
2014 (12460)
2013 (10634)
2012 (11435)
2011 (11980)
2010 (10930)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (57)
Arkansas (3)
Asia (20171)
Australia (2619)
California (1794)
Canada (930)
China (248)
Colorado (71)
Connecticut (70)
Delaware (61)
Europe (39551)
Florida (343)
Georgia (39)
Idaho (9)
Illinois (202)
India (16)
Indiana (137)
Iowa (1)
Japan (96)
Kansas (58)
Kentucky (13)
Louisiana (1)
Maine (2)
Maryland (264)
Massachusetts (1538)
Michigan (30)
Minnesota (95)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (789)
New Mexico (7)
New York (533)
North Carolina (404)
North Dakota (2)
Northern California (735)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (460)
Puerto Rico (8)
Rhode Island (10)
South America (502)
South Carolina (2)
Southern California (751)
Tennessee (34)
Texas (239)
United States (7477)
Utah (34)
Virginia (78)
Washington D.C. (31)
Washington State (123)
Wisconsin (18)
267,057 Results for "laguna pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company’s President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA.
March 13, 2024
·
2 min read
Lone Star Bio
Elligo Health Research Teams With Laguna Clinical Research Associates
Elligo Health Research, a leading integrated research organization with relationships and access to over 150 million patients and their data, announced its partnership with Laguna Clinical Research Associates.
May 18, 2021
·
2 min read
Press Releases
X4 Pharmaceuticals Announces Reverse Stock Split
April 24, 2025
·
6 min read
Pharm Country
electroCore to Participate in Upcoming Investor Conferences
electroCore, Inc. announced today that the Company’s Chief Strategy Officer, Joshua Lev, is scheduled to attend the 36th Annual Roth Conference taking place at The Ritz Carlton Laguna Niguel in Dana Point, California on March 17 – 19, 2024.
March 12, 2024
·
1 min read
Biotech Beach
Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
Revelation Biosciences Inc. announced today that its Chief Executive Officer James Rolke will participate in a virtual fireside chat at the 36th Annual Roth Conference scheduled for March 17-19, 2023 to be held at The Ritz Carlton, Laguna Niguel in Dana Point, California.
March 12, 2024
·
1 min read
Pharm Country
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
Helius Medical Technologies, Inc. announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the 36th Annual ROTH Conference, March 17-19, 2024, Laguna Nigel, CA, as follows.
March 7, 2024
·
2 min read
BioCapital
Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14th
Adial Pharmaceuticals, Inc. today announced that Cary Claiborne, President and Chief Executive Officer of Adial, will be presenting at the 35th Annual Roth Conference being held March 13 - 14, 2023 at The Ritz Carlton, Laguna Niguel.
March 8, 2023
·
1 min read
Press Releases
KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
April 8, 2025
·
4 min read
1 of 26,706
Next
